MYX mayne pharma group limited

Ann: 2022 Half Year Investor Presentation, page-141

  1. 1,468 Posts.
    lightbulb Created with Sketch. 289
    Something needs happen soon to put some life into this lifeless stock , its as if we're dead and wont lie down . Right now its its all about hoping something will happen to breath some life into Mayne . Nuvaring (generic) approval , Nextstellis good market response to justify product promotion costs and evidence of satisfactory sale numbers , also need an end in sight to our seeming endless write downs and more on our board who helped get us into our loss making mess gone replaced by competent qualified people who have a proper understanding of the business we're in .
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$5.08
Change
0.160(3.25%)
Mkt cap ! $409.4M
Open High Low Value Volume
$4.93 $5.09 $4.93 $2.011M 400.9K

Buyers (Bids)

No. Vol. Price($)
5 379 $5.07
 

Sellers (Offers)

Price($) Vol. No.
$5.10 3034 3
View Market Depth
Last trade - 15.58pm 24/06/2025 (20 minute delay) ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.